eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cushing syndrome |
| Comorbidity | C0020456|hyperglycemia |
| Sentences | 3 |
| PubMedID- 23558873 | Background: mifepristone is approved to control hyperglycemia in adults with endogenous cushing's syndrome and is described as a mildly qtc prolonging drug, based on a tqt study. |
| PubMedID- 25560275 | Mifepristone, a glucocorticoid receptor antagonist, has been approved for hyperglycemia associated with cushing's syndrome based on the results of a prospective study where it produced in the majority of patients' significant clinical and metabolic improvement. |
| PubMedID- 22674211 | Mifepristone (a glucocorticoid receptor antagonist) is another promising drug, recently approved by the fda for treatment of hyperglycemia associated with cushing's syndrome. |
Page: 1